Europe Inhalation Anesthesia Market Size, Share & Industry Trends Analysis Report By Drug (Sevoflurane, Desflurane, Isoflurane, and Others), By Application (Maintenance and Induction), By Country and Growth Forecast, 2022 - 2028

The Europe Inhalation Anesthesia Market would witness market growth of 8.5% CAGR during the forecast period (2022-2028).

During surgical procedures, anesthetic drugs are used to manage pain, respiration, blood pressure, blood flow, and heart rate and rhythm. Inhalational anesthesia is mostly used for sedation and induction of general anesthesia. Sevoflurane, desflurane, and nitrous oxide are the most often used inhalational anesthetics. Respiratory depression, a decrease in arterial blood pressure and cerebral metabolic demand, and an increase in cerebral blood flow are all common side effects of inhalational anesthetics. Nausea is the most prevalent side effect of inhalation anesthesia.

Halothane, isoflurane, nitrous oxide, sevoflurane, and desflurane are the most often utilized anesthetic gases. Inhalation through a face mask, laryngeal mask airway, or tracheal tube is the most common method of delivery. In the perioperative and intraoperative environment, they can be used in addition to intravenous (IV) anesthetic drugs such as midazolam and propofol for preoperative sedation.

According to estimates, the UK's healthcare spending in 2020 will be over £269 billion, including both government and non-government spending. Long-term care services relating to health are included. Between 2019 and 2020, total healthcare spending increased by 20% in nominal terms. This was by far the fastest year-over-year rate of increase in healthcare spending since the time series began in 1997.

In 2020, healthcare spending will account for 12.8 percent of GDP, up from 10.2 percent in 2019. The coronavirus pandemic had a substantial influence on both the healthcare sector and the wider economy, and this large increase was partially owing to very strong growth in healthcare expenditure but also partly due to a decline in GDP. The increase in healthcare expenditure is estimated to lead to an increase in the demand for inhalation anesthesia in the region.

The Germany market dominated the Europe Inhalation Anesthesia Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $124 Million by 2028. The UK market is anticipated to grow at a CAGR of 7.6% during (2022 - 2028). Additionally, The France market would display a CAGR of 9.3% during (2022 - 2028).

Based on Drug, the market is segmented into Sevoflurane, Desflurane, Isoflurane, and Others. Based on Application, the market is segmented into Maintenance and Induction. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Inhalation Anesthesia Market will Hit $1.9 Billion by 2028, at a CAGR of 8.7%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novartis AG, Piramal Enterprises Limited, Hikma Pharmaceuticals PLC, Fresenius SE & Co. KGaA, Baxter International, Inc., AbbVie, Inc., Halocarbon Products Corporation, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., and Troikaa Pharmaceuticals Limited.

Scope of the Study

Market Segments Covered in the Report:

By Drug

• Sevoflurane
• Desflurane
• Isoflurane
• Others

By Application

• Maintenance
• Induction

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Novartis AG
• Piramal Enterprises Limited
• Hikma Pharmaceuticals PLC
• Fresenius SE & Co. KGaA
• Baxter International, Inc.
• AbbVie, Inc.
• Halocarbon Products Corporation
• Jiangsu Hengrui Pharmaceuticals Co., Ltd.
• Lunan Pharmaceutical Group Co., Ltd.
• Troikaa Pharmaceuticals Limited

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Inhalation Anesthesia Market, by Drug
1.4.2 Europe Inhalation Anesthesia Market, by Application
1.4.3 Europe Inhalation Anesthesia Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Inhalation Anesthesia Market by Drug
3.1 Europe Sevoflurane Market by Country
3.2 Europe Desflurane Market by Country
3.3 Europe Isoflurane Market by Country
3.4 Europe Others Market by Country

Chapter 4. Europe Inhalation Anesthesia Market by Application
4.1 Europe Maintenance Market by Country
4.2 Europe Induction Market by Country

Chapter 5. Europe Inhalation Anesthesia Market by Country
5.1 Germany Inhalation Anesthesia Market
5.1.1 Germany Inhalation Anesthesia Market by Drug
5.1.2 Germany Inhalation Anesthesia Market by Application
5.2 UK Inhalation Anesthesia Market
5.2.1 UK Inhalation Anesthesia Market by Drug
5.2.2 UK Inhalation Anesthesia Market by Application
5.3 France Inhalation Anesthesia Market
5.3.1 France Inhalation Anesthesia Market by Drug
5.3.2 France Inhalation Anesthesia Market by Application
5.4 Russia Inhalation Anesthesia Market
5.4.1 Russia Inhalation Anesthesia Market by Drug
5.4.2 Russia Inhalation Anesthesia Market by Application
5.5 Spain Inhalation Anesthesia Market
5.5.1 Spain Inhalation Anesthesia Market by Drug
5.5.2 Spain Inhalation Anesthesia Market by Application
5.6 Italy Inhalation Anesthesia Market
5.6.1 Italy Inhalation Anesthesia Market by Drug
5.6.2 Italy Inhalation Anesthesia Market by Application
5.7 Rest of Europe Inhalation Anesthesia Market
5.7.1 Rest of Europe Inhalation Anesthesia Market by Drug
5.7.2 Rest of Europe Inhalation Anesthesia Market by Application

Chapter 6. Company Profiles
6.1 Novartis AG
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches and Product Expansions:
6.2 Piramal Enterprises Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Hikma Pharmaceuticals PLC
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.4 Fresenius SE & Co. KGaA
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.5 Baxter International, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Approvals and Trials:
6.6 AbbVie, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 Halocarbon Products Corporation
6.7.1 Company Overview
6.8 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
6.8.1 Company Overview
6.9 Lunan Pharmaceutical Group Co., Ltd.
6.9.1 Company Overview
6.10. Troikaa Pharmaceuticals Limited
6.10.1 Company Overview

TABLE 1 Europe Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 2 Europe Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 3 Europe Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 4 Europe Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 5 Europe Sevoflurane Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Sevoflurane Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Desflurane Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Desflurane Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Isoflurane Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Isoflurane Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 14 Europe Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 15 Europe Maintenance Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Maintenance Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Induction Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Induction Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Inhalation Anesthesia Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Inhalation Anesthesia Market by Country, 2022 - 2028, USD Million
TABLE 21 Germany Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 22 Germany Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 23 Germany Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 24 Germany Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 25 Germany Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 26 Germany Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 27 UK Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 28 UK Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 29 UK Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 30 UK Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 31 UK Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 32 UK Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 33 France Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 34 France Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 35 France Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 36 France Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 37 France Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 38 France Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 39 Russia Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 40 Russia Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 41 Russia Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 42 Russia Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 43 Russia Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 44 Russia Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 45 Spain Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 46 Spain Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 47 Spain Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 48 Spain Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 49 Spain Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 50 Spain Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 51 Italy Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 52 Italy Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 53 Italy Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 54 Italy Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 55 Italy Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 56 Italy Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 57 Rest of Europe Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 58 Rest of Europe Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 59 Rest of Europe Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 60 Rest of Europe Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 61 Rest of Europe Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 62 Rest of Europe Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 63 Key Information – Novartis AG
TABLE 64 Key Information – Piramal Enterprises Limited
TABLE 65 Key Information – Hikma Pharmaceuticals PLC
TABLE 66 key information – Fresenius SE & Co. KGaA
TABLE 67 Key Information – Baxter International, Inc.
TABLE 68 Key information – AbbVie, Inc.
TABLE 69 Key Information – Halocarbon Products Corporation
TABLE 70 Key Information – Jiangsu Hengrui Pharmaceuticals Co., Ltd.
TABLE 71 Key Information – Lunan Pharmaceutical Group Co., Ltd.
TABLE 72 key Information – Troikaa Pharmaceuticals Limited

List of Figures
FIG 1 Methodology for the research